GB9811598D0 - Diagnosis and treatment of cancer - Google Patents

Diagnosis and treatment of cancer

Info

Publication number
GB9811598D0
GB9811598D0 GBGB9811598.3A GB9811598A GB9811598D0 GB 9811598 D0 GB9811598 D0 GB 9811598D0 GB 9811598 A GB9811598 A GB 9811598A GB 9811598 D0 GB9811598 D0 GB 9811598D0
Authority
GB
United Kingdom
Prior art keywords
diagnosis
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9811598.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB9811598.3A priority Critical patent/GB9811598D0/en
Publication of GB9811598D0 publication Critical patent/GB9811598D0/en
Priority to PCT/GB1999/001720 priority patent/WO1999063110A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB9811598.3A 1998-05-30 1998-05-30 Diagnosis and treatment of cancer Ceased GB9811598D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB9811598.3A GB9811598D0 (en) 1998-05-30 1998-05-30 Diagnosis and treatment of cancer
PCT/GB1999/001720 WO1999063110A1 (en) 1998-05-30 1999-06-01 Diagnosis and treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9811598.3A GB9811598D0 (en) 1998-05-30 1998-05-30 Diagnosis and treatment of cancer

Publications (1)

Publication Number Publication Date
GB9811598D0 true GB9811598D0 (en) 1998-07-29

Family

ID=10832928

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9811598.3A Ceased GB9811598D0 (en) 1998-05-30 1998-05-30 Diagnosis and treatment of cancer

Country Status (2)

Country Link
GB (1) GB9811598D0 (en)
WO (1) WO1999063110A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1320618A (en) * 2000-04-27 2001-11-07 上海博德基因开发有限公司 Polypeptide-human Pax protein 12.5 and polynucleotide for coding it
CN1320616A (en) * 2000-04-27 2001-11-07 上海博德基因开发有限公司 Polypeptide-human Pax protein 17 and polynucleotide for coding it
CN1321664A (en) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 Novel polypeptide-human pax protein 23 and polynucleotide for coding this polypeptide
CN1321655A (en) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 Novel polypeptide-human pax protein 10.3 and polynucleotide for coding this polypeptide
CN1321654A (en) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 Novel polypeptide-human pax protein 11.4 and polynucleotide for coding this polypeptide
CN1321656A (en) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 Novel polypeptide-human Pax protein 11 and polynucleotide for coding this polypeptide
CN1322752A (en) * 2000-05-09 2001-11-21 上海博德基因开发有限公司 New polypeptide human Pax protein 22 and its encoding polynucleotides
CN1322755A (en) * 2000-05-09 2001-11-21 上海博德基因开发有限公司 New polypeptide human Pax protein 9 and its encoding polynucleotides
EP1352089B1 (en) 2000-08-25 2006-12-06 Lovelace Respiratory Research Institute Nested methylation-specific polymerase chain reaction cancer detection method
WO2003064682A1 (en) * 2001-10-18 2003-08-07 Lovelace Respiratory Research Institute Cancer monitoring by aberrant promotor methylation of the transcription factor genes pax5 alpha pax5 beta, novel loop helix loop protein, novel gene 2, and beta3 genes
EP1361268A1 (en) * 2002-05-08 2003-11-12 Boehringer Ingelheim International GmbH Pax-5-deficient pro-B cells, methods of producing them and the use of such cells in human therapy
US7217515B2 (en) 2002-09-30 2007-05-15 Chi Mei Foundation Medical Center HURP gene as a molecular marker for bladder cancer
SG186109A1 (en) * 2010-06-02 2013-01-30 Abraxis Bioscience Llc Methods of treating bladder cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4225569C2 (en) * 1992-08-03 1996-04-25 Max Planck Gesellschaft Use of a probe for tumor diagnosis or tumor therapy

Also Published As

Publication number Publication date
WO1999063110A1 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
GB9903841D0 (en) Diagnosis and treatment of cancer
EP0831904A4 (en) Treatment and diagnosis of prostate cancer
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
IL140845A0 (en) Compositions for therapy and diagnosis of prostate cancer
EP1007535A4 (en) Methods and compositions for diagnosis and treatment of breast cancer
GB9824436D0 (en) Methods of treatment
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
IL132287A0 (en) Compositions and methods for the treatment and diagnosis of breast cancer
PT1716853E (en) Treatment of cancers of the human body using et743
GB9811598D0 (en) Diagnosis and treatment of cancer
IL138692A0 (en) Treatment and prevention of vascular disease
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
GB9911772D0 (en) Diagnosis and treatment of atherosclerosis
PL350863A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
GB9812550D0 (en) Tumour therapy and imaging
GB9819999D0 (en) Treatment of cancer
IL149281A0 (en) Treatment of cancer
EP0918788A4 (en) Brca1 compositions and methods for the diagnosis and treatment of breast cancer
EP1023076A4 (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
GB9908059D0 (en) Diagnosis and treatment of diseases
GB2343629B (en) Treatment of cellulite
GB9828564D0 (en) Materials and methods for the treatment and diagnosis of cancer
GB9606293D0 (en) Treatment of cancers and other tumours

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)